Novartis Gets Femara FDA Priority Review
5th Sep 2005, 11:57 GMT
Swiss drug maker Novartis AG said that the FDA granted priority review to its breast cancer treatment Femara to treat earlier forms of the disease.
Source:Mammography News from myHealthcareNews.com Language:English Domain:More feeds from myhealthcarenews.com:
|
Novartis Gets Femara FDA Priority Review5th Sep 2005, 11:57 GMT Swiss drug maker Novartis AG said that the FDA granted priority review to its breast cancer treatment Femara to treat earlier forms of the disease. Latest news from Mammography News from myHealthcareNews.com: |